• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Radiosurgery

Fresenius Kabi expands compatibility of radio frequency tagged medication

June 14, 2022 By Sean Whooley

Fresenius Kabi logo updated

Fresenius Kabi announced today that its portfolio of radio frequency tagged medications is now compatible with an AmerisourceBergen offering. Lake Zurich, Illinois-based Fresenius Kabi’s growing +RFID portfolio now has compatibility with AmerisourceBergen’s medication tray solution for helping hospitals improve medication inventory visibility and tracking using advanced radiofrequency identification (RFID) technology. Get the full story at […]

Filed Under: Auto-injectors, Business/Financial News, Hospital Care, Radiosurgery Tagged With: AmerisourceBergen, freseniuskabi

Boston Scientific warns on some SpaceOAR systems

March 21, 2022 By Sean Whooley

Boston Scientific

Boston Scientific (NYSE:BSX) has issued an urgent field safety notice in Europe due to potential issues with its SpaceOAR systems. Marlborough, Massachusetts-based Boston Scientific’s SpaceOAR system is an absorbable polyethylene glycol hydrogel spacer for separating the prostate from the rectal wall during radiation treatment for prostate cancer. The SpaceOAR Vue, the next-generation hydrogel spacer, offers enhanced […]

Filed Under: Featured, Hydrogels, Oncology, Radiosurgery, Recalls, Regulatory/Compliance Tagged With: Boston Scientific

FDA approves Novocure’s NovoTTF-100LTM plus chemo for mesothelioma

May 24, 2019 By Danielle Kirsh

novocure logo

NovoCure (NSDQ:NVCR) announced that it has received FDA approval for its NovoTTF-100L system with chemotherapy for treating a type of mesothelioma. NovoTTF-100L is a non-invasive, antimitotic cancer treatment designed to deliver electric fields at special frequencies to disrupt solid tumor cancer cell division. Approved under a humanitarian device exemption, NovoTTF-100L and pemetrexed plus platinum-based chemotherapyis indicated […]

Filed Under: Oncology, Radiosurgery, Regulatory/Compliance Tagged With: NovoCure

NovoCure’s Q2 sales top forecast, earnings miss

July 26, 2018 By Brad Perriello

Novocure

NovoCure (NSDQ:NVCR) shares are under pressure this morning after the company reported second-quarter losses that exceeded estimates. The British firm’s losses fell -26.7% to -$15.5 million, or -17¢ per share, on sales growth of 60.3% to $61.5 million for the three months ended June 30. Analysts on Wall Street were looking for losses of -16¢ per […]

Filed Under: Featured, MassDevice Earnings Roundup, Radiosurgery, Wall Street Beat Tagged With: NovoCure

Varian Medical to pay $1.3B for Sirtex

January 30, 2018 By Brad Perriello

Varian to acquire Sirtex

Varian Medical (NYSE:VAR) yesterday said it agreed to pay nearly $1.3 billion for Australia’s Sirtex Medical (ASX:SRX) and its anti-cancer microspheres. The A$28-per-share offer, which values Sirtex at A$1.59 billion (about $1.28 billion), is slated to close in late May, Palo Alto, Calif.-based Varian said. It’s part of a bid to broaden that company’s oncology portfolio. Sirtex makes […]

Filed Under: Featured, Mergers & Acquisitions, Oncology, Radiosurgery, Wall Street Beat Tagged With: Sirtex Medical, Varian Medical Systems

Medtech stories we missed this week: Oct. 27, 2017

October 27, 2017 By Danielle Kirsh

missedmedtech-1027

From RadiaDyne’s FDA expansion to NuVasive launching its new implants, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA expands indications for RadiaDyne’s OARtrac dose monitor RadiaDyne announced in an Oct. 24 press release that it has received additional FDA clearance for its upcoming OARtrac. The OARtrac allows […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Neurological, Radiosurgery, Regulatory/Compliance Tagged With: Alcyone Lifesciences, Implanet, medtech, nuvasive, Ortek Therapeutics, radiadyne, Tau Consortium, Varian Medical Systems

Novocure gains on additional Optune data

April 17, 2017 By Brad Perriello

Novocure

Shares in Novocure (NSDQ:NVCR) are on the rise again after the company today cited additional data from a pivotal trial evaluating its Optune device with temozolomide chemotherapy as a treatment for newly-diagnosed glioblastoma. Novocure’s Optune mobile device delivers low-intensity, intermediate frequency, alternating electric fields, called “tumor treating fields” or TTFields, to inhibit cancer cell replication. The […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Oncology, Radiosurgery, Wall Street Beat Tagged With: NovoCure

Novocure touts long-term analysis of Optune drug-device combo

September 12, 2016 By Sarah Faulkner

Novocure

Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival data for nearly 700 patients confirmed interim results from the trial, 1st published in December 2015 in the Journal of the American Medical Assn. Patients treated […]

Filed Under: Clinical Trials, Drug-Device Combinations, Radiosurgery Tagged With: NovoCure

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS